Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
10x Genomics, Inc. Banner

10x Genomics, Inc.

TXG Stock Analysis

Page title

Section title

Breakdown
2017
2018
2019
2020
2021
2022
2023
Net Income
-18.762m-112.485m-31.251m-542.731m-58.223m-166.000m-255.099m
Depreciation & Amortization
4.305M3.905M7.066M19.021M28.254M33.006M43.619M
Change in Working Capital
1.948M28.015M44.764M-50.381m-87.445m-39.417m17.343M
Operating Cash Flow
-10.699m-76.409m34.627M-217.898m-21.373m-33.606m-15.197m
Capital Expenditure
-3.756m-6.709m-42.767m-38.394m-101.278m-131.661m-49.524m
Free Cash Flow
-14.455m-83.118m-8.140m-256.292m-122.651m-165.267m-64.721m
Debt Repayment
-393.000k-773.000k-11.000m-37.104m-5.028m-5.409m-5.814m
Dividends Paid
0.0000.0000.0000.0000.0000.0000.000
Common Stock Issued
21.056M1.798M410.824M506.010M40.325M21.226M19.483M
Common Stock Repurchased
-80.000k0.0000.0000.0000.0000.0000.000
Net Change in Cash
6.114M22.231M406.405M212.151M-92.571m-368.720m136.905M